Results 221 to 230 of about 33,934 (312)
Development and Validation of Prediction Models for the Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Population-Based Cohort Study. [PDF]
Chen L +5 more
europepmc +1 more source
ABSTRACT Objective To investigate risk factors for refractory Helicobacter pylori infection (RHPI) complicated by chronic atrophic gastritis (CAG) and to develop a risk prediction model for early identification of high‐risk patients. Methods A retrospective cohort study enrolled 367 RHPI patients from January 2015 to December 2024.
Tian‐tong Jiang +10 more
wiley +1 more source
Integrating CD45 + CD3+ and CD3 + CD8+ T-cell markers into nomograms for predicting survival in gastroesophageal junction carcinoma. [PDF]
Song Y, Wang Z, Ma J, Li Y, Su R.
europepmc +1 more source
ABSTRACT Background Although immune checkpoint inhibitors (ICIs) have revolutionized the treatment of nasopharyngeal carcinoma (NPC), reliable predictive biomarkers need to be further explored. This study aimed to investigate the predictive ability of inflammatory markers for poor prognosis in NPC patients treated with ICIs. Methods In this multicenter
Yang Xu +12 more
wiley +1 more source
Development and validation of a predictive model for early postoperative pain after cesarean section. [PDF]
Xu P, Huang H, Qiu G, Cheng H, Feng L.
europepmc +1 more source
ABSTRACT Objective This study aimed to develop and validate an MRI‐based DeltaHabitat radiomics model to predict pathological complete response (pCR) in oral cavity squamous cell carcinoma (OCSCC) patients treated with neoadjuvant chemoimmunotherapy. Methods Patients treated with neoadjuvant chemoimmunotherapy and surgery were retrospectively included ...
Lin Ding +8 more
wiley +1 more source
Prognostic Role of CA19-9 in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. [PDF]
Masuda T +7 more
europepmc +1 more source
ABSTRACT Background Health‐related quality of life (HRQOL) measures patients' overall well‐being and can help guide survivorship care. Evidence comparing individual patients' HRQOL pre‐ and post‐diagnosis is limited due to the unpredictable nature of cancer onset.
Kaelyn C. Cummins +6 more
wiley +1 more source
Perioperative serum carcinoembryonic antigen: Powerful marker for prognostic prediction and adjuvant chemotherapy decision-making in patients with stage II and III colorectal cancer. [PDF]
Du FQ +9 more
europepmc +1 more source

